Literature DB >> 21796114

Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label.

D Menon-Andersen1, B Yu, R Madabushi, V Bhattaram, W Hao, R S Uppoor, M Mehta, L Lesko, R Temple, N Stockbridge, T Laughren, J V Gobburu.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21796114     DOI： 10.1038/clpt.2011.149

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  13 in total

1.  Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test.

Authors:  Xu Steven Xu; Min Yuan; Haitao Yang; Yan Feng; Jinfeng Xu; Jose Pinheiro
Journal:  AAPS J       Date:  2016-10-19       Impact factor: 4.009

2.  The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice.

Authors:  Gunnar Alván; Marine L Andersson; Annika B Asplund; Ylva Böttiger; Carl-Eric Elwin; Lars L Gustafsson; Birgitta Öhman; Elisabeth Törnqvist
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

3.  Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer.

Authors:  Jianguo Li; Nidal Al-Huniti; Anja Henningsson; Weifeng Tang; Eric Masson
Journal:  Br J Clin Pharmacol       Date:  2017-03-27       Impact factor: 4.335

4.  Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.

Authors:  Spencer Y Ling; Robert B Huizinga; Patrick R Mayo; Richard Larouche; Derrick G Freitag; Launa J Aspeslet; Robert T Foster
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

5.  Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity.

Authors:  Xu Steven Xu; Min Yuan; Hao Zhu; Yaning Yang; Hui Wang; Honghui Zhou; Jinfeng Xu; Liping Zhang; Jose Pinheiro
Journal:  Br J Clin Pharmacol       Date:  2018-05-03       Impact factor: 4.335

6.  Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?

Authors:  Marc Maliepaard; Anne C Taams; Cynthia Sung; Jalene Poh; Yang Yu
Journal:  Pharmaceut Med       Date:  2019-10

7.  Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package.

Authors:  Jean-Francois Marier; Nathan Teuscher; Mohamad-Samer Mouksassi
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-27

8.  Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.

Authors:  Anne-Gaëlle Dosne; Elodie Valade; Kim Stuyckens; Peter De Porre; Anjali Avadhani; Anne O'Hagan; Lilian Y Li; Daniele Ouellet; Ruben Faelens; Quentin Leirens; Italo Poggesi; Juan Jose Perez Ruixo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-11-22

Review 9.  Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.

Authors:  Stephanie Faucette; Santosh Wagh; Ashit Trivedi; Karthik Venkatakrishnan; Neeraj Gupta
Journal:  Clin Transl Sci       Date:  2017-12-19       Impact factor: 4.689

10.  Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma.

Authors:  Yan Feng; Eric Masson; David Dai; Susan M Parker; David Berman; Amit Roy
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.